Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03490929 · ClinicalTrials.gov registry record · Phase 4
CEUS for Blunt Abdominal Trauma in Children
A Phase 4 study of Trauma Abdomen, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 146
- Enrollment target
- 2
- Study locations
NCT03490929 is a Phase 4 study of Trauma Abdomen that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 146 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03490929, a Phase 4 study of Trauma Abdomen, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 146 participants
- Enrollment target
- 2
- Study locations
Study Summary
Children with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some promise as a way to detect intra-abdominal organ injury and may be able to replace the need for conventional CT scanning, without the need for ionizing radiation and the ability to be performed at the bedside.
Conditions Studied
Interventions
- DRUG Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
- DEVICE contrast-enhanced ultrasound
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03490929
The ClinicalTrials.gov registry entry for NCT03490929 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trauma Abdomen appearing as the primary indexed condition, and to 2 interventions - of which Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON] is the first listed.
NCT03490929 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03490929 about?
NCT03490929 is a clinical study titled "CEUS for Blunt Abdominal Trauma in Children". Children with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some promise as a way to det...
What is the current status of trial NCT03490929?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 146 participants. The study started on 2018-06-01. Estimated completion is 2026-12-31.
What conditions does trial NCT03490929 study?
This clinical trial studies the following conditions: Trauma Abdomen.
What interventions are being tested in trial NCT03490929?
The interventions under investigation include: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON] (DRUG), contrast-enhanced ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03490929?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03490929 being conducted?
This trial has 2 study locations across Minnesota, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.